Cost pressures ease, fundamentals improve
Opportunities arising out of USD 33 billion worth of drugs coming off patent in CY06 and CY07, easing of pricing pressures in developed markets, consolidation in the pharma sector, and improving fundamentals are some of the factors that may help the...